Fewer, But Larger, Local Bioscience Funding Deals
Acelyrin Buys Maryland Immunotherapy Firm
Execs Hired At Acelyrin
Acelyrin Raises $300M to Further Growth
Business Events Calendar
Worthe Starts 30-Acre Burbank Project
OpEd: Policy Creates Solar Blind Spot
FloQast Raises $100 Million, Eyes IPO
WeWork Amends Lease in NoHo